Align Technology vs Dr. Reddy's Laboratories

Align Technology (ALGN), health care, and Dr. Reddy's Laboratories (RDY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Dr. Reddy's Laboratories is worth $12.3B on the stock market and Align Technology $11.5B: Dr. Reddy's Laboratories is valued at 7% more. Align Technology trades at 23.8 times earnings and Dr. Reddy's Laboratories at 41.1; operating margins in their latest fiscal years were 13.5% and 15.0%. Over the past year Align Technology's share price has moved +25.5% and Dr. Reddy's Laboratories's +4.85%.

Key facts

Align Technology market value
$11.5B
Dr. Reddy's Laboratories market value
$12.3B
Align Technology P/E
23.8
Dr. Reddy's Laboratories P/E
41.1
Align Technology revenue
$4BFY to 2025-12-31
Dr. Reddy's Laboratories revenue
$3.6BFY to 2026-03-31
Superinvestors holding both
0

Market values as of .

Align Technology vs Dr. Reddy's Laboratories: every measure side by side
Measure Align Technology Dr. Reddy's Laboratories
SectorHealth CareHealth Care
Country United States India
Fiscal year ends2025-12-312026-03-31
Size
Market cap$11.5Blower$12.3Bhigher
Revenue$4Bhigher$3.6Blower
Earnings$410.4Mlower$456Mhigher
Employees20,180lower27,527higher
Total assets$6.2Bhigher$6.2Blower
Valuation
P/E23.8lower41.1higher
P/S2.9lower3.4higher
P/B2.7—
Dividend yield0.00%—
Profitability
Operating margin13.5%lower15.0%higher
Balance sheet
Net assets$4Bhigher$4Blower
Total liabilities$2.2Bhigher$2.1Blower
Total debt—$193.7M
Cash on hand$1.1Bhigher$163.5Mlower
Price change
Today-1.52%lower+0.61%higher
1 year+25.5%higher+4.85%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Align Technology only (2)

Dr. Reddy's Laboratories only (0)

None of the tracked investors.

Percentages are each holding's share of that investor's reported portfolio. Who owns ALGN · Who owns RDY

Further comparisons

Learn

Questions and answers

Which is bigger, Align Technology or Dr. Reddy's Laboratories?

By market value, Dr. Reddy's Laboratories is the larger: $12.3B against $11.5B for Align Technology. By revenue in its latest fiscal year, Align Technology is the larger: $4B against $3.6B for Dr. Reddy's Laboratories.

Which has the higher P/E ratio?

Dr. Reddy's Laboratories: 41.1, against 23.8 for Align Technology. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Dr. Reddy's Laboratories: 15.0%, against 13.5% for Align Technology. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which superinvestors own both Align Technology and Dr. Reddy's Laboratories?

None of the tracked superinvestors holds both in their latest 13F filing. 2 hold Align Technology and 0 hold Dr. Reddy's Laboratories.

Cite this page

Funkfolio, “Align Technology vs Dr. Reddy's Laboratories”, data as of 18 November 2026. https://funkfolio.com/compare/algn-vs-rdy

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.